Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.
Publication
, Journal Article
Becker, RC; Scheiman, J; Dauerman, HL; Spencer, F; Rao, S; Sabatine, M; Johnson, DA; Chan, F; Abraham, NS; Quigley, EMM ...
Published in: J Am Coll Cardiol
December 8, 2009
The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
December 8, 2009
Volume
54
Issue
24
Start / End Page
2261 / 2276
Location
United States
Related Subject Headings
- Thrombosis
- Stents
- Risk Factors
- Risk Assessment
- Platelet Aggregation Inhibitors
- Humans
- Hemorrhage
- Endoscopy, Gastrointestinal
- Coronary Artery Disease
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C., Scheiman, J., Dauerman, H. L., Spencer, F., Rao, S., Sabatine, M., … American College of Gastroenterology, . (2009). Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. J Am Coll Cardiol, 54(24), 2261–2276. https://doi.org/10.1016/j.jacc.2009.09.012
Becker, Richard C., James Scheiman, Harold L. Dauerman, Frederick Spencer, Sunil Rao, Marc Sabatine, David A. Johnson, et al. “Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.” J Am Coll Cardiol 54, no. 24 (December 8, 2009): 2261–76. https://doi.org/10.1016/j.jacc.2009.09.012.
Becker RC, Scheiman J, Dauerman HL, Spencer F, Rao S, Sabatine M, et al. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. J Am Coll Cardiol. 2009 Dec 8;54(24):2261–76.
Becker, Richard C., et al. “Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.” J Am Coll Cardiol, vol. 54, no. 24, Dec. 2009, pp. 2261–76. Pubmed, doi:10.1016/j.jacc.2009.09.012.
Becker RC, Scheiman J, Dauerman HL, Spencer F, Rao S, Sabatine M, Johnson DA, Chan F, Abraham NS, Quigley EMM, American College of Cardiology, American College of Gastroenterology. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. J Am Coll Cardiol. 2009 Dec 8;54(24):2261–2276.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
December 8, 2009
Volume
54
Issue
24
Start / End Page
2261 / 2276
Location
United States
Related Subject Headings
- Thrombosis
- Stents
- Risk Factors
- Risk Assessment
- Platelet Aggregation Inhibitors
- Humans
- Hemorrhage
- Endoscopy, Gastrointestinal
- Coronary Artery Disease
- Cardiovascular System & Hematology